Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-115
Closed -$9 4831
2025
Q2
$9 Hold
115
﹤0.01% 4876
2025
Q1
$83 Hold
115
﹤0.01% 3904
2024
Q4
$137 Hold
115
﹤0.01% 3910
2024
Q3
$386 Hold
115
﹤0.01% 3169
2024
Q2
$627 Sell
115
-1,150
-91% -$6.46K ﹤0.01% 3066
2024
Q1
$1.31K Buy
1,265
+1,150
+1,000% +$6.55K ﹤0.01% 2793
2023
Q4
$719 Hold
115
﹤0.01% 2844
2023
Q3
$550 Hold
115
﹤0.01% 3095
2023
Q2
$688 Hold
115
﹤0.01% 3147
2023
Q1
$2.44K Hold
115
﹤0.01% 2829
2022
Q4
$2K Hold
115
﹤0.01% 4102
2022
Q3
$2K Hold
115
﹤0.01% 4310
2022
Q2
$2K Hold
115
﹤0.01% 4073
2022
Q1
$2K Hold
115
﹤0.01% 4073
2021
Q4
$6K Hold
115
﹤0.01% 2396
2021
Q3
$7K Hold
115
﹤0.01% 2399
2021
Q2
$10K Buy
+115
New +$10.5K ﹤0.01% 2193

IFP Advisors's AFMD Position: Q3 2025 in Review

IFP Advisors sold out of Affimed (AFMD) in Q3 2025, closing a stake of 115 shares — an estimated $9 sold.

IFP Advisors first reported a position in AFMD in Q2 2021 and held it in 17 quarters. The position peaked at $10K in Q2 2021. 0 funds tracked by Wall St. Rank hold AFMD as of Q3 2025.

  • IFP Advisors reported no remaining Affimed position as of Q3 2025 after selling out during the quarter.
  • IFP Advisors sold 115 Affimed shares in Q3 2025, an estimated $9.
  • IFP Advisors first reported a position in Affimed in Q2 2021 and held it in 17 quarters.
  • IFP Advisors's Affimed position peaked at $10K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Affimed as of Q3 2025.

Based on IFP Advisors's 13F filing for Q3 2025, filed 2 Dec 2025.